BIT
Click for more information
0.00% 3.0¢ biotron limited

cash up front or take over is very near, page-13

  1. J8
    14,558 Posts.
    lightbulb Created with Sketch. 826
    clock Created with Sketch.
    23/08/14
    11:49
    Post #: 13861341
    Is this the sort of deal Michelle might chase? Thinking more along the HIV front for outside interest in BIT225.



    Johnson & Johnson ($JNJ) has deepened its ties to regenerative medicine outfit ViaCyte, handing the biotech $20 million in exchange for a future stake in the company and the right to acquire its in-development diabetes medication. Under the deal, J&J's cash buys it a note convertible into equity and an exclusive chance to acquire VC-01, ViaCyte's stem cell-derived treatment for Type 1 diabetes.
    BIT Price at posting: 13.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $27.06M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $3.082K 103.5K

Buyers (Bids)

No. Vol. Price($)
2 707862 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 125010 4
View Market Depth
Last trade - 11.20am 09/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.